Beranda › Limfoma Sel B Besar Difus › South Dakota
Uji klinis Limfoma Sel B Besar Difus di South Dakota
3 studi untuk Limfoma Sel B Besar Difus mencari peserta di lokasi di South Dakota.
Kota di South Dakota
Teks studi resmi (Bahasa Inggris)
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
- Avera Cancer Institute, Sioux Falls
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06500273A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
- Sanford Cancer Center ( Site 0143), Sioux Falls
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06717347Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Sanford Children's Hospital-Sanford Children's Specialty Clinic ( Site 1015), Sioux Falls
Menerima pesertaFase 1/2
6 Months – 25 Years · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT06395103Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.